Tysabri every eight weeks may cut PML risk
Tysabri every eight weeks may cut PML risk
Preliminary findings from an ongoing study of multiple sclerosis patients suggest the dosing interval for Tysabri can be as much as doubled from the label-recommended standard without sacrificing efficacy, and with potentially less risk of progressive multifocal leukoencephalopathy (PML) -- even among patients with more than average PML risk, researchers claim... Read More - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2533 Views
-
Last post by NHE
-
- 6 Replies
- 7302 Views
-
Last post by ElliotB
-
- 0 Replies
- 1414 Views
-
Last post by NHE
-
- 0 Replies
- 3756 Views
-
Last post by NHE
-
- 1 Replies
- 1142 Views
-
Last post by NHE
-
- 1 Replies
- 1695 Views
-
Last post by NHE
-
- 11 Replies
- 3526 Views
-
Last post by NHE
-
- 0 Replies
- 3456 Views
-
Last post by NHE
-
- 0 Replies
- 1605 Views
-
Last post by NHE